在心脏移植中使用捐赠者simvastatin治疗
在PubMed上查看摘要
概括
此摘要是机器生成的。在心脏移植之前给器官捐赠者服用simvastatin可显著降低接受者的心肌损伤生物标志物. 这种安全且廉价的辅助疗法有望改善移植结果.
科学领域
- 心脏病学
- 移植医学
- 药理学
背景情况
- 缺血再输血损伤 (IRI) 对心脏移植的预后产生负面影响.
- 实验数据表明,给器官捐赠者服用simvastatin可以提供血管保护并减轻心脏移植IRI.
研究的目的
- 评估给多器官捐赠者的simvastatin在接受心脏移植后减少心肌损伤的疗效.
主要方法
- 一项随机试验涉及84名多器官捐赠者,其中42人接受了80毫克的simvastatin,42人作为对照.
- 主要终点:受试者24小时内手术后的血中T和I水平.
- 二次终点:血液动力学,炎症,异种移植功能,排斥和死亡率.
主要成果
- 在捐赠者中,simvastatin治疗显著降低了接受者的T (34%) 和I (40%) 输血后水平.
- 观察到NT-proBNP水平降低 (36%) 和血液动力学损害的排斥治疗较少 (53%).
- 对供体脂质没有显著影响,但受体肌肉细胞基因表达和炎症标志物 (CXCL10,IL- 1α) 发生变化.
结论
- 在接受心脏移植的患者中,捐赠者simvastatin有效降低了心肌损伤的生物标志物.
- 鉴于simvastatin的安全性,它可以作为多器官捐赠的新且具有成本效益的辅助疗法.
相关概念视频
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
The heart is a hollow, muscular organ approximately the size of a fist, consisting of four chambers. It is enclosed in the pericardium, a fibrous sac with two layers: the visceral and parietal pericardium, separated by a fluid-filled space containing serous fluid to reduce friction.
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
The heart, a muscular organ located in the chest, functions as the body's pump, circulating blood through the vascular system. It has four chambers: two atria on top and two ventricles below. The right atrium receives deoxygenated blood from the body and passes it to the right ventricle, which pumps it to the lungs for oxygenation. The left atrium receives oxygenated blood from the lungs and transfers it to the left ventricle, which pumps it to the rest of the body.
The heart's structure...
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

